Laryngeal Cancer Treatment and Survival Differences across Regional Cancer Centres in Ontario, Canada

Clinical Oncology

Volumn 23, Issue 1, 2011, Pages 19-28

  Groome, P A ^a   O'Sullivan, B ^b   Mackillop, W J ^a   Irish, J ^b   Schulze, K ^a   Jackson, L D ^a   Bissett, R J ^c   Dixon, P F ^c   Eapen, L J ^c   Gulavita, S P ^c   Hammond, J A ^c   Hodson, D I ^c   Mackenzie, R G ^c   Schneider, K M ^c   Warde, P R ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c CANCER CARE ONTARIO   (Canada)

Author keywords

Cause specific survival; Health services research; Laryngeal cancer; Population based; Practice variations

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANADA; CANCER CENTER; CANCER RADIOTHERAPY; CANCER SURVIVAL; CASE MIX; CAUSE OF DEATH; FEMALE; HUMAN; LARYNGECTOMY; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CANCER CARE FACILITIES; COHORT STUDIES; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; MALE; MIDDLE AGED; ONTARIO; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 78650415358     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2010.08.027     Document Type: Article

References (30)

1. Groome P.A., O'Sullivan B., Irish J., et al. Management and outcome differences in supraglottic cancer between Ontario, Canada and the SEER areas of the United States. J Clin Oncol 2003, 21:496-505.
2. Jackson L.D., Groome P.A., Schulze K., et al. Radiotherapy patterns of practice: T1N0 glottic cancer in Ontario, Canada. Clin Oncol 2003, 15:266-279.
3. Groome P.A., O'Sullivan B., Mackillop W.J., et al. Compromised local control due to treatment interruptions and late treatment breaks in early glottic cancer: population-based outcomes study supporting need for intensified treatment schedules. Int J Radiat Oncol Biol Phys 2006, 64:1002-1012.
4. TNM classification of malignant tumours 1997, John Wiley and Sons, New York. 5th ed. L.H. Sobin, C. Wittekind (Eds.).
5. Skladowski K., Tarnawski R., Maciejewski B., Wygoda A., Slosarek K. Clinical radiobiology of glottic T1 squamous cell carcinoma. Int J Radiat Oncol Biol Phys 1999, 43:101-106.
6. Fowler J.F. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989, 62:679-694.
7. Robertson A.G., Robertson C., Boyle P., Symonds R.P., Wheldon T.E. The effect of differing radiotherapeutic schedules on the response of glottic carcinoma of the larynx. Eur J Cancer B Oral Oncol 1993, 29A:501-510.
8. Ang K.K., Thames H.D., Peters L.J. Altered fractionation schedules. Principles and practice of radiation oncology 1997, 119-142. Lippincott-Raven, Philadelphia. C.A. Perez, L.W. Brady (Eds.).
9. Cancer in Ontario 1993-1994 1995, The Ontario Cancer Treatment and Research Foundation, Toronto. K. Kwaitkowska (Ed.).
10. Lau B., Cole S.R., Gange S.J. Competing risk regression models for epidemiologic data. Am J Epidemiol 2009, 170:244-256.
11. Lustig R.A., Maclean C.J., Hanks G.E., Kramer S. The patterns of care outcome studies: results of the national practice in carcinoma of the larynx. Int J Radiat Oncol Biol Phys 1984, 10:2357-2362.
12. Lustig R.A., Krall J.M., Curran W.J., Hanks G.E. Improvements observed in care and outcome in carcinoma of the larynx. Int J Radiat Oncol Biol Phys 1991, 20:101-104.
13. Hoffman H.T., Porter K., Karnell L.H., et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 2006, 116(9 Pt 2 Suppl. 111):1-13.
14. Chen A.Y., Schrag N., Hao Y., et al. Changes in treatment of advanced laryngeal cancer 1985-2001. Otolaryngol Head Neck Surg 2006, 135:831-837.
15. Priestman T.J., Bullimore J.A., Godden T.P., Deutsch G.P. The Royal College of Radiologists' fractionation survey. Clin Oncol 1989, 1:39-46.
16. Edwards D.M., Johnson N.W. Treatment of upper aerodigestive tract cancers in England and its effect on survival. Br J Cancer 1999, 81:323-329.
17. Groome P.A., O'Sullivan B., Irish J.C., et al. Glottic cancer in Ontario, Canada and the SEER areas of the United States: do different management philosophies produce different outcome profiles?. J Clin Epidemiol 2001, 54:301-315.
18. Bradley P.J., Zutshi B., Nutting C.M. An audit of clinical resources available for the care of head and neck cancer patients in England. J Laryngol Otol 2005, 119:620-626.
19. James N.D., Robertson G., Squire C.J., Forbes H., Jones K., Cottier B. RCR Clinical Oncology Audit Sub-committee: a national audit of radiotherapy in head and neck cancer. Clin Oncol 2003, 15:41-46.
20. Mackillop W.J., Fu H., Quirt C.F., Dixon P., Brundage M., Zhou Y. Waiting for radiotherapy in Ontario. Int J Radiat Oncol Biol Phys 1994, 30:221-228.
21. Cancer Care Ontario Radiation treatment wait times Available at:, Accessed 9 September 2009. http://csqi.cancercare.on.ca.
22. Fortin A., Bairati I., Albert M., Moore L., Allard J., Couture C. Effect of treatment delay on outcome of patients with early-stage head-and-neck carcinoma receiving radical radiotherapy. Int J Radiat Oncol Biol Phys 2002, 52:929-936.
23. Huang J., Barbera L., Brouwers M., Browman G., Mackillop W.J. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 2003, 21:555-563.
24. Cheung M.C., Koniaris L.G., Perez E.A., Molina M.A., Goodwin W.J., Salloum R.M. Impact of hospital volume on surgical outcome for head and neck cancer. Ann Surg Oncol 2009, 16:1001-1009.
25. Hall S., Schulze K., Groome P., Mackillop W., Holowaty E. Using cancer registry data for survival studies: the example of the Ontario Cancer Registry. J Clin Epidemiol 2006, 59:67-76.
26. Barbera L., Groome P.A., Mackillop W.J., et al. The role of computed tomography in the T classification of laryngeal carcinoma. Cancer 2001, 91:394-407.
27. Bourhis J., Overgaard J., Audry H., et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 2006, 368:843-854.
28. Goepfert H. Advanced laryngeal cancer: current best management: "The paradigm is shifting, but not much" Curr Opin Otolaryngol Head Neck Surg 2002, 10:112-117.
29. Delaney G., Jacob S., Barton M. Estimation of an optimal external beam radiotherapy utilization rate for head and neck carcinoma. Cancer 2005, 103:2216-2227.
30. List M.A., Bilir S.P. Functional outcomes in head and neck cancer. Semin Radiat Oncol 2004, 14:178-189.